Oncology Research Team
Download
Report
Transcript Oncology Research Team
Role of the Oncology Research
Team
Carmen B. Jacobs, RN, OCN, CCRP
Oncology Research Team
•
•
•
•
•
•
Clinical Research Associate/ Research Nurse
Nurse/ Resident
Pharmacist
Support Staff (administrative)
Data Manager / Data Entry Clerk
Trial Participant, according to GCP
Clinical Research Associate /
Research Nurse
• The role can be the same depending on the
structure of the program.
• Clinical Manager
– Research Nurses
• Research Manager
– Clinical Research Associates
– Regulatory Staff
Duties of the CRA or RN
•
•
•
•
Screens for potential candidates
Determines eligibility
Aids in consent process
Schedules patient contacts, appointments,
develop personalized study calendar
• Reviews treatment orders
• Documents adverse events – monitors patients
symptoms
• Instructs patient on QOL questionnaires
Duties of the CRA or RN
• Follows study parameters and assess for any
treatment modifications needed
• Avoids any deviations or violations to the
protocol
• Liaison between the patient and the physician
investigator
• Assures compliance with IRB, FDA, GCP, NIH
and cooperative groups / sponsor
requirements
CRA / Research Nurse
• Wright and colleagues
– Patients first approached by a physician vs. a CRA,
and then those patients whose decision was
solicited by a CRA vs. a physician were more likely
to enter a clinical trial.
•
Wright, et al. JCO 22(21) 2004: 4312-4318
CRA / RN Role
• Plays a role on patient’s perception of the
clinical trial
– assesses any communication or education
barriers
– explains the clinical trial in a language the patient
can understand
– establishes trust between the patient and the
research team
CRA / RN
1.
protocol compliance
6.
Patient recruitment
2.
Clinical trials related
communication
7.
Ethical issues
8.
Financial implications
9.
Professional development
3.
Informed consent process
4.
Management of clinical trial
patients
5.
Documentation
Resident
• A medical resident can also act as a CRA,
while taking care of patients that are
participating in a clinical trial.
• He/ she could be instrumental in assessing
together with the physician investigator the
side effects and toxicities caused by the
investigational drug.
Pharmacist
• Reviews and standardizes treatment protocol
• Adjusts dosing for changes according to the
protocol
• Logs and monitors use of IND agents
• Maintains study drug for patients
• Drug accountability and inventory
• Assures accurate blinding procedures
• Participates in IRB and hospital pharmacy
committees
Data Manager / Data Entry clerk
• submits data collected by the research nurse
or CRA (paper or electronic)
• checks for accuracy of data to be submitted
• assists with the accurate and timely
submission of adverse events and serious
adverse events as mandated by the FDA
• ships all pathology specimens to sponsor as
required
Data Manager / Data Entry clerk
• Meets with monitors for pharmaceutical trial
• Prepares for cooperative group audits
• Schedules monitor visits
Support Staff (administrative)
•
•
•
•
•
•
•
manages daily operations
coordinates financial paper work
completes budgets and contracts
manages all grant activities
marketing
staff education
Standard operating procedures updates and
overview
• Accrual reports
CRA Coordinator / Manager
•
•
•
•
•
Supervises program / CRAs
Budgets, cost accounting, financial planning
Negotiates contracts with sponsors
Physician investigator liaison
Maintains list of open protocols, consents and
eligibility
• Schedules and monitors initiation and
auditing visits by study sponsors
CRA Coordinator / Manager
• Assures compliance with IRB, FDA, GCP, NIH
and other government or sponsor
requirements
• Monitors regulatory documents ( C.V.s, lab
normals and certifications (CLIA), financial
disclosures, 1572).
Trial Participant
• The most important person in the clinical trial
is the patient.
• There should be concern to not directly bias
patients or families.
• Informed consent process documentation
should show there was no coercion and that
the patient was provided all information
necessary for an informed consent.
• Emphasis on safe patient care.
“Kind words can be short and easy
to speak, but their echoes are truly
endless.”
Mother Theresa